Rosenberg Matthew Hamilton Neurocrine Biosciences Inc Transaction History
Rosenberg Matthew Hamilton
- $336 Million
- Q2 2024
A detailed history of Rosenberg Matthew Hamilton transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Rosenberg Matthew Hamilton holds 4 shares of NBIX stock, worth $456. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4
Previous 4
-0.0%
Holding current value
$456
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
640Shares Held
95.2MCall Options Held
661KPut Options Held
227K-
Black Rock Inc. New York, NY14.2MShares$1.62 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.15 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$525 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$281 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$269 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...